What is the primary objective of this study?
Compared with AN69 hemofilter, AN69 ST hemofilter may prolong the time of hemofilter and
decrease the quantity of heparin during continuous renal replacement therapy in critically
ill.
Who is eligible to participate?
Inclusion Criteria:
- age> 18 years old
- admitted to ICU and need CRRT
- anticipated survival time >72h
Exclusion Criteria:
- allergy to hemofilter or heparin
- heparin associated thrombocytopenia
- pregnancy or lactation
- using other anticoagulate drugs
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Critically Ill
Acute Kidney Injury
Septic Shock
Study Interventions
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Device:AN 69 ST hemofilter
Device:AN 69 hemofilter
Study Arms
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
AN 69 ST hemofilterUse AN 69 ST hemofilter during CRRT
AN 69 hemofilterUse AN 69 hemofilter during CRRT
Study Status
Unknown status
Start Date: January 2012
Completed Date:
Phase: N/A
Type: Interventional
Design:
Primary Outcome: The using time of hemofilters
Secondary Outcome: activated partial thromboplastin time
Study sponsors, principal investigator, and references
Principal Investigator:
Lead Sponsor: Zhongda Hospital
Collaborator:
More information:https://clinicaltrials.gov/show/NCT01823484
PatientsVille.com
